UNeMed

MENU
  • Home
  • About
    • About Us
    • Annual Reports
    • Careers & Education
    • FAQs
    • In the News
    • Pipeline
    • Staff Directory
    • Board of Directors
    • Startups
    • Success Stories
  • Services
    • Confidentiality
    • Intellectual Property
    • Inventions
    • Licensing Process
    • Material Transfer
    • Startup Formation
    • Work with Us
  • Technologies
    • Cancer
    • Cardiovascular
    • COVID-19
    • Drug delivery
    • Infectious Diseases
    • Medical Devices
    • Metabolic
    • Neurologic
    • Open-MediciNE
    • Other
    • Research Tools
    • Software
    • Pipeline
    • Technology Portfolio
  • Resources
    • Intellectual Property
    • Entrepreneurial Calendar
    • FAQs
    • Forms & Policies
    • Funding
    • Patents
    • Pipeline
    • Departments
    • Inventor Handbook
    • Technology Portfolio
    • More
      • UNMC Research
      • UNMC China
      • Nano Production
      • UNMC Core Facilities
      • UNL Core Facilities
      • iEXCEL
  • I-Week
    • Innovation Week
    • Innovation Awards
    • Demo Day
    • Past Events
  • Startups
  • News
    • Wearable tech startup, sim lab expo on tap for Idea...

      Read article

    • Omaha startup clears FDA, will hit market this month

      Read article

    • Morning Edition APRIL 2025

      Next Morning Edition set for April 24, surgical startup to...

      Read article

    • Fast Company March 2025 Cover

      Fast Company lists Virtual Incision among world’s ‘Most Innovative Companies’

      Read article

    • HemaGlobal opens Morning Edition at Catalyst

      Read article

  • Blog
    • What I learned as a tech transfer intern

      Read article

    • Year in Review: Highlights from 2024

      Read article

    • Innovation, entrepreneurs abound at UNMC nursing

      Read article

    • Top UNMC innovator looks for problems, find solutions

      Read article

    • UNeMed President and CEO Michael Dixon, PhD, (right) presents UNMC researcher Rebekah Gundry,PhD, with the 2023 Emerging Inventor award during the Innovation Awards ceremony on Thursday, Nov. 2, 2023

      Year in Review: Highlights from 2023

      Read article

  • Contact
    • Contact Us
    • Staff Directory

Cancer

UNMC technologies in the oncology field available for licensing

Showing all 12 resultsSorted by latest

  • ProGel

    ProGel

    Read more
  • Anti-INHBA siRNA

    Anti-INHBA siRNA

    Read more
  • MIBG Analogs

    MIBG Analogs

    Read more
  • CDK9 PROTACs

    CDK9 PROTACs

    Read more
  • Metformin nanoformulation

    Metformin nanoformulation

    Read more
  • Claudin-1 Inhibitors

    Claudin-1 Inhibitors

    Read more
  • GGDPS Inhibitors

    GGDPS Inhibitors

    Read more
  • Microtubule targeted therapeutics, imaging agents

    Microtubule targeted therapeutics, imaging agents

    Read more
  • NF-κB Pathway Inhibitor

    NF-κB Pathway Inhibitor

    Read more
  • Breast cancer biomarker

    Breast cancer biomarker

    Read more
  • NF-kB inhibitors

    NF-kB inhibitors

    Read more
  • Nanogel cancer treatment

    Nanogel cancer treatment

    Read more

unemed  
  • Cancer (12)
  • Cardiovascular (4)
  • COVID-19 (13)
  • Drug delivery (9)
  • Infectious Diseases (24)
  • Medical Devices (45)
  • Metabolic (3)
  • Neurologic (2)
  • Online Store (15)
  • Open-MediciNE (2)
  • Other (11)
  • Research Tools (17)
  • Software (19)
unemed UNeMed
986099 Nebraska Medical Center
Omaha, NE 68198-6099
402-559-2468
unemed@unmc.edu
  • About
  • Services
  • Technologies
  • Resources
  • Innovation Week
  • News
  • Blog
  • Contact

Photos on flickr

  • UNeMed
  • Privacy Policy
  • Terms & Conditions of Use

© 2025 UNeMed | All Rights Reserved. Contact Webmaster.